Authors



Katherine Marino, MD

Latest:

Alcohol Exposure in Pregnancy Has No Adverse Effect on Birth Weight

Despite the general consensus that excessive alcohol consumption should be avoided prior to and during pregnancy, there is very little data on the effects alcohol consumption in early gestation has on birth outcomes.



Anthony J. Orsini, DO

Latest:

5 Quick Ways to Become A Better Patient Communicator

Re-establishing the doctor-patient bond is critical, especially in an era of more informed patients and increasing physician burnout.


Kim Farina-Graham, PhD

Latest:

What Are Your Options When Treating Painful Diabetic Neuropathy in Primary Care?

The best setting for the treatment of painful diabetic neuropathy is primary care, where diabetes and its associated chronic pain can be managed as a single entity. The American Diabetes Association defines diabetic peripheral neuropathy (DPN) as "the presence of symptoms and/or signs of peripheral nerve dysfunction in patients with diabetes after exclusion of other causes." Approximately 16% of diabetic patients will experience painful diabetic neuropathy (PDN).


Thomas Castles & Mary Caffrey

Latest:

Tom Price Resigns Amid Flight Chartering Controversy

Price was found to have chartered more than 2 dozen flights, racking up roughly $400,000 in extraneous costs.


Robert Helm, MD is fellow, Division of Cardiology

Latest:

Benefits of early statin treatment in patients with acute myocardial infarction

Numerous clinical trials have shown that HMG CoA reductase inhibitor (statin) therapy reduces the risk of myocardial infarction (MI), stroke, and mortality in patients with cardiovascular disease.



Rachel K. Berlin, MS IV

Latest:

Can a Smoking Cessation Drug Cause Neuropsychiatric Adverse Events?

When encouraging and supporting patients to quit smoking, varenicline is unlikely to increase the risk of neuropsychiatric adverse events such as suicide, depression, and aggression, even in patients with pre-existing psychiatric illness.


William O. Ntim, MB, ChB

Latest:

Contemporary cardiac imaging in hypertrophic obstructive cardiomyopathy

Features of hypertrophic obstructive cardiomyopathy (HOCM) include obstruction at the left ventricular outflow tract (caused by a markedly thickened proximal interventricular septum) and systolic anterior motion of the mitral valve. The case discussed here illustrates several classic features of this disease including clinical presentation, diagnostic workup, and noninvasive and invasive management.


GUIDO R. ZANNI, PHD

Latest:

Patient Education: Diabetic Neuropathy

This resource describes several measures that patients with diabetes can take to prevent or control diabetic neuropathy, including peripheral neuropathy.



Fabio Pellegrini, MStat1

Latest:

Antithrombotic treatment of high-risk elderly patients hospitalized with atrial fibrillation

We assessed the pattern of use and the effectiveness of antithrombotic therapy in a cohort of high-risk elderly patients hospitalized for atrial fibrillation, with data derived from prescription, hospitalization, and mortality databases from 3 linked registries. Results showed that antithrombotic therapy was underused, even in patients with no comorbid conditions. In addition, patients exposed to antithrombotic therapy had a significantly lower mortality rate. The collection of epidemiological data by record linkage represents a flexible and readily available tool for monitoring and improving routine clinical care.




B?rge G. Nordestgaard, MD, DMSc: From the Department of Clinical Biochemistry, Herlev University Hospital

Latest:

Nonfasting triglycerides and ischemic heart disease in men and women

Triglyceride levels are usually measured after the patient has fasted, and then exclude remnant lipoproteins. Except for the first few hours of the morning, individuals are usually in a nonfasting state for most of the day. We investigated whether nonfasting triglyceride levels predicted the risk of myocardial infarction (MI), ischemic heart disease, and death in the general population. Results showed that increased nonfasting triglyceride levels were associated with an increased risk of MI, ischemic heart disease, and death.


Kate Huvane

Latest:

In Our Brave New World, Health 2.0 Is Changing How Physicians Communicate with Patients

The boom of social networking should make it easier for physicians and patients to communicate with one another. But reimbursement, liability, and privacy concerns are getting in the way. How can these obstacles be overcome? Read on.




Desiree Cox, MBBS, PhD

Latest:

The Power of 'Big Data' and the Impact of Screening on Hepatitis C Survival Rates

A large multinational observational study of patients with hepatitis C reveals etiology does not play a major role in HCV survival rates and that early detection and access to treatment have a greater impact.



Yves L. Bayard

Latest:

Transcatheter occlusion of the left atrial appendage to prevent stroke in atrial fibrillation

We conducted 2 feasibility studies to assess the performance and safety of the percutaneous left atrial appendage (LAA) transcatheter occlusion system for the prevention of stroke in high-risk patients with nonrheumatic atrial fibrillation. Results showed that percutaneous LAA occlusion can be performed using the device at acceptable risk. This procedure may be particularly useful for patients at increased risk of ischemic stroke with a contraindication to anticoagulation therapy.



John J. Ricotta, MD

Latest:

Carotid atherosclerosis and increased high-density lipoprotein

The report by Johnsen and colleagues details the changes in plaque composition and size as defined by duplex ultrasound at 2 time points 7 years apart


KarLa K. Quevedo, MD

Latest:

Efficacy of Beta-Blockers in Patients with Heart Failure Plus Atrial Fibrillation

Atrial fibrillation (AF) and heart failure (HF) often coexist. The use of beta-blockers in HF patients has a class 1A recommendation in both the European and American guidelines. In current guidelines for heart failure therapy, the recommendation for beta-blockers is not restricted to patients with sinus rhythm, and includes all HF patients.






© 2024 MJH Life Sciences

All rights reserved.